Researchers at the University of California, San Diego School of Medicine, University of Pittsburgh and elsewhere describe the first human tests of using a perfluorocarbon (PFC) tracer in combination with non-invasive magnetic resonance imaging (MRI) to track therapeutic immune cells injected into patients with colorectal cancer.
UC San Diego Sulpizio Cardiovascular Center (SCVC) has been named among "100 Hospitals with Great Heart Programs" by Becker's Hospital Review, a business and legal news publication for hospital and health system leadership.
Researchers at University of California, San Diego School of Medicine have identified a control mechanism for an area of the brain that processes sensory and emotive information that humans experience as “disappointment.”
Thermo Fisher Scientific and the UC San Diego Office of Research Affairs have established the Duane Roth Innovation Grant, which provides scientific investigators at UC San Diego with a $50,000 annual funding opportunity for sponsored research that supports proof-of-concept and technology-applications studies.
A trip to the Guatemalan jungle usually nets a few souvenirs: Photographs of Maya ruins, bragging rights about encounters with venomous snakes, perhaps a bug bite or two.
Researchers at the University of California, San Diego School of Medicine have launched a phase 1 human clinical trial to assess the safety and efficacy of a new monoclonal antibody for patients with chronic lymphocytic leukemia (CLL), the most common form of blood cancer in adults.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
